外陰膣カンジダ症に対するフルコナゾールの研究

基本情報

NCT ID

NCT01806623

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

157

治験依頼者名

Pfizer

概要

As for the indication of vulvovaginal candidiasis, a single oral administration of fluconazole 150 mg has been approved and is recommended by guidelines overseas. However in Japan oral therapy with antifungal triazole such as Fluconazole has not been approved, and topical therapies such as vaginal tablets, pessary and cream are used clinically. The purpose of this trial is to confirm the efficacy and safety of single oral administration of fluconazole 150 mg for the treatment of vulvovaginal candidiasis in Japanese patients.

対象疾患

介入

依頼者（Sponsor）

実施施設 (10)